Effect of ResvidaTM on fat oxidation and mitochondrial biogenesis in healthy obese subjects - ResvidaTM and mitochondrial function

niversiteit Maastricht0 个研究点目标入组 18 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•* Female sex
•* Unstable body weight (weight gain or loss > 3 kg in the last three months)
•* Total body fat (%) < 25%
•* Fasting plasma glucose > 6.1 mmol/l
•HB < 7.8 mmol/l
•* Engagement in programmed exercise > 2 hours total per week
•* Impaired kidney and/ or hepatic function
•* First- or second-degree family member with type 2 diabetes mellitus
•* Any medical condition requiring treatment and/or medication use
•* Intake of dietary supplements except vitamins and minerals
•* Unwilling to restrict high-resveratrol-containing foods
•* Current alcohol consumption > 20 grams/day
•* Participation in another biomedical study within 1 month before the first screening visit
•* A contraindication to MRI scanning. These contra-indications include patients with the following devices:
•o Central nervous system aneurysm clips
•o Implanted neural stimulator
•o Implanted cardiac pacemaker of defibrillator
•o Cochlear implant
•o Insulin pump
•o metal containing corpora aliena in the eye or brains

发起方